Summary:
The Thrive-IVF Research Study is currently seeking participants at approximately 15-20 clinical research sites in major metropolitan areas across the US. The study is evaluating the efficacy, safety and tolerability of NT100, an investigational medicine, in women who have had repeated IVF failures despite having good-quality embryos.
NT100 is a novel treatment that is being evaluated to determine if it improves your chances of getting pregnant after IVF.
Qualified participants will receive study-related tests and procedures at no cost, including:
- An IVF cycle, including procedures and medications
- Study medication